Related Experiment Video
Updated: Aug 6, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
The shifting burden of early-onset inflammatory bowel disease: a global analysis
Chaoyan Yue1, Ziyi Zhou2, Leilei Fang3
1Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Insights
Global mortality from early-onset inflammatory bowel disease (EO-IBD) in children decreased significantly, yet socioeconomic disparities in mortality persist. Targeted prevention and equitable care are crucial, especially in resource-limited settings.
Area of Science:
- Pediatric Gastroenterology
- Global Health Epidemiology
- Health Disparities Research
Background:
- Early-onset inflammatory bowel disease (EO-IBD), affecting children under 10, is a growing global pediatric concern.
- Current data are insufficient to fully characterize the global burden and socioeconomic disparities of EO-IBD.
- Understanding these disparities is critical for developing effective public health strategies.
Purpose of the Study:
- To comprehensively assess global trends in EO-IBD incidence, mortality, prevalence, and DALYs from 1990 to 2021.
- To analyze cross-national disparities and socioeconomic inequalities in EO-IBD burden.
- To evaluate shifts in mortality burden across different Socio-demographic Index (SDI) levels.
Main Methods:
- Utilized Global Burden of Disease 2021 data for 204 countries and territories.
- Applied decomposition analysis, inequality metrics, and frontier benchmarking.
- Examined temporal trends and burden shifts across SDI levels.
Main Results:
- Global EO-IBD mortality declined by approximately 70% between 1990 and 2021; incidence remained stable.
- Prevalence increased, indicating a growing population of children living with EO-IBD.
- High-SDI regions had higher incidence but lower mortality, with a shifting mortality burden toward lower-SDI populations.
Conclusions:
- Significant socioeconomic inequalities in EO-IBD mortality persist globally.
- Diverging mortality and incidence trends highlight the need for equitable healthcare access.
- Urgent need for targeted preventive strategies and improved monitoring of pediatric health system equity worldwide.
Background:
Early-onset inflammatory bowel disease (EO-IBD), affecting children under age 10 years, has an emerged as a distinct global pediatric health concern with increasing clinical and epidemiological features. Existing data, however, remain insufficient to characterize its full global burden or associated socioeconomic disparities.
Methods:
Using Global Burden of Disease 2021 data, we analyzed EO-IBD incidence, mortality, prevalence, and disability-adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021. Decomposition analysis, inequality metrics, and frontier benchmarking were applied to assess temporal trends, cross-national disparities, and burden shifts across levels of Socio-demographic index (SDI).
Results:
Between 1990 and 2021, global EO-IBD mortality declined by roughly 70%, while incidence remained relatively stable. Prevalence rose, reflecting a growing population of children living with the condition. High-SDI regions recorded the highest incidence but the lowest mortality. Inequality analyses pointed a shifting mortality burden toward lower-SDI populations, and frontier analysis revealed substantial health system performance disparities independent of socioeconomic status.
Conclusions:
This comprehensive global assessment of EO-IBD in children reveals diverging mortality and incidence trends alongside persistent socioeconomic inequalities. The findings underscore the urgent need for equitable healthcare access and targeted preventive strategies worldwide, and improved monitoring of pediatric health system equity.
Impact:
Global mortality from early-onset inflammatory bowel disease (EO-IBD) declined by approximately 70% between 1990 and 2021. Despite substantial progress, marked socioeconomic inequalities in EO-IBD mortality persist across regions. This study provides the first comprehensive global assessment of EO-IBD mortality trends and disparities. The findings highlight the need for equitable pediatric IBD care and targeted prevention strategies in resource-limited settings.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:26Inflammatory Bowel Disease I: Introduction